Mitigating the cardiovascular risk of anemia in patients with type 2 diabetes and CKD: Does darbepoetin help? The TREAT Trial.
Hayes
Christi
C
Department of Medicine, State University of New York-Downstate Medical Center and Kings County Hospital, Brooklyn, 11203, USA.
Alam
Anis
A
Black-Peart
Julie
J
McFarlane
Samy I
SI
D000740:Anemia / Q000150:complications* / Q000188:drug therapy*; D002318:Cardiovascular Diseases / Q000150:complications*; D000068256:Darbepoetin alfa; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D004921:Erythropoietin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors
D004921:Erythropoietin; D000068256:Darbepoetin alfa